Announcements Trials

Browse Landscape

Phase

Phase NA 6 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hematologic Neoplasms 2 Sunburn 1 Skin Neoplasms 1 Pulmonary Disease, Chronic Obstructive 1 Mucositis 1 Lymphoma 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Cigarette Smoking-Related Carcinoma 1 Chronic Pain 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma in Situ 1 Brenner Tumor 1 Breast Neoplasms 1 Arthralgia 1 Anatomic Stage I Breast Cancer AJCC v8 1 Abnormalities, Radiation-Induced 1

Interventions

Cyclophosphamide 60 Vincristine 57 Doxorubicin 54 Rituximab 48 Prednisone 44 Etoposide 35 Radiotherapy 34 Cytarabine 26 Filgrastim 22 Methotrexate 21 Bleomycin 21 Dexamethasone 18 Peripheral Blood Stem Cell Transplantation 14 Carmustine 14 Vinblastine 13 Prednisolone 13 VAP-cyclo protocol 12 Melphalan 12 Mitoxantrone 11 Mercaptopurine 10 Leucovorin 10 Dacarbazine 9 Ifosfamide 8 Granulocyte Colony-Stimulating Factor 8 Procarbazine 7 Methylprednisolone 7 Lenalidomide 7 Gemcitabine 7 Daunorubicin 7 Cisplatin 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma × Educational Status × Clear all

NCT05006482 2026-01-13

GEM-S

University of Rochester

Phase 3 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡